Filters

Bid (21F10) Monoclonal Antibody

Bid (21F10) Monoclonal Antibody size: 0.1ml 362

Price 362
Size 0.1ml
Long nameBid (21F10) Monoclonal Antibody
Also known asBid (21F10) Monoclonal Antibody
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenBid
SpecificityThis is a highly specific antibody against Bid
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityMonoclonal
Clone number21F10
Concentration1ug per 1ul
SourceRecombinant human protein purified from E, coli(His-Bid)
Gene ID number637
Swiss ProtP55957
Tested Applications IP, WB
Recommended dilutions0ug/mL) IP (2ug), WB (1
Cross reactivityHuman
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Counters the protective effect of Bcl-2, Isoform 1, Isoform 3 does not induce apoptosis, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis, The major proteolytic product p15 BID allows the release of cytochrome c (By similarity)
Purification methodPurified by Protein G
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names BH3-interacting domain death agonist, BID, p22 BID, FP497
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
About Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones
Gene targetBid (21F10) Monoclonal
Short nameBid (21F10) Monoclonal Antibody
Technique Monoclonals or monoclonal antibodies, antibodies against human proteins, antibodies for, Antibody
Alternative nameBH3 interacting domain death a this GO nist (21F10) monoclonal (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter